...
首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Platelet count and platelet‐lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta‐analysis
【24h】

Platelet count and platelet‐lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta‐analysis

机译:血小板计数和血小板淋巴细胞比例作为头部和颈部鳞状细胞癌的预后标志:META分析

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background Thrombocytosis is associated with the prognosis of various types of cancer. The purpose of this study was to quantify the prognostic impact of platelet count and platelet‐lymphocyte ratio (PLR) in head and neck squamous cell carcinoma (HNSCC). Methods We systematically searched electronic databases and identified articles reporting an association between platelet count or PLR and HNSCC prognosis. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall survival (OS) were extracted, and the pooled HRs were estimated using random effect models. Results Eight studies that enrolled 4096 patients and 9 studies that enrolled 2327 patients were included in the platelet count and PLR analyses, respectively. A platelet count greater than the cutoff value was associated with poor OS (HR 1.81; 95% CI 1.16‐2.82) and any PLR greater than the cutoff value was associated with poor OS (HR 1.64; 95% CI 1.13‐2.37). Conclusion Elevated platelet count and PLR are associated with poor prognosis in patients with HNSCC.
机译:摘要背景血小板症与各种类型癌症的预后有关。本研究的目的是量化血小板计数和血小板淋巴细胞比(PLR)在头部和颈部鳞状细胞癌(HNSCC)中的预后影响。方法我们系统地搜索了电子数据库并确定了报告血小板计数或PLR和HNSCC预后之间关联的文章。提取危险比(HRS)和95%置信区间(HRS)和95%的总存活(OS)的置信区间(CIS),并使用随机效果模型估计合并的HRS。结果八项研究,注册了4096名患者和9项注册2327名患者的研究,分别包括在血小板计数和PLR分析中。大于截止值的血小板计数与差的OS(HR 1.81; 95%CI 1.16-2.82)相关,并且任何大于截止值的PLR与差的OS(HR 1.64; 95%CI 1.13-2.37)相关。结论血小板计数升高,PLR与HNSCC患者的预后不良有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号